Last updated: July 24, 2023
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Ocular Hypertension
Glaucoma
Treatment
Boston keratoprosthesis type 1 and anterior hyaloid membrane peeling assisted by endoscopy
Clinical Study ID
NCT04337944
CE19.382
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged from 18 to 80 years old
- Informed consent
- Boston keratoprosthesis candidate
- Pars plana vitrectomy candidate
- Ability to be followed for the duration of the study
Exclusion
Exclusion Criteria:
- Aged less than 18 or more than 80 years old
- Inability to give informed consent
- Repeat Boston keratoprosthesis
- Repeat pars plana vitrectomy
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Boston keratoprosthesis type 1 and anterior hyaloid membrane peeling assisted by endoscopy
Phase:
Study Start date:
April 08, 2020
Estimated Completion Date:
March 31, 2025
Study Description
Connect with a study center
Centre Hospitalier de l'Université de Montréal (CHUM)
Montréal, Quebec H2X 3E4
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.